SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Uniting the six native Japanese dog breeds. Kendu is the keeper of peace, the preserver of life, and the protector of unity. Join the pack!!

Kendu

Kendu is trending due to its strong community and growing holder count, signaling increasing interest and conviction. The community is actively discussing the potential for a major rally, driven by the expectation of a significant move in the dawg coin sector. Many believe $KENDU.X is undervalued and primed for substantial growth, emphasizing its real-world applications and brand development.

Dog (Bitcoin) is a fully decentralized memecoin on the Bitcoin blockchain, backed by a community dedicated to onboarding millions of people to Bitcoin.  Dog is secured by the Bitcoin blockchain and exists on Bitcoin L1, marking a significant innovation compared to Bitcoin with just BTC. Dog is a Bitcoin Runes token with a minimal on-chain footprint, native to Bitcoin, and stored in UTXOs, just like Bitcoin.   What is the project about?  Dog does not do any paid promotion and is fully decentralized just like Bitcoin. Every influencer who chooses to post about Dog either received the airdrop or bought on secondary. Dog leverages the CC0 license to ensure that Dog is not owned by any single entity but rather by everyone. This had lead to the "DOG Army" independently creating art, apps, lotteries, plushies, websites, podcast, magazines, X account, IRL meetups, clothing lines, PFP collections, Telegram groups, and TikTok/Instagram about Dog.  What makes your project unique?  Dog was airdropped in the fairest memecoin launch ever. In early 2024, the Bitcoin Ordinals ecosystem came together in a full volunteer initiative that rewarded early adopters of the Ordinals Protocol. There was no team allocation, and 100% of the supply was airdropped for free. The airdrop algorithm favored neither whales nor influencers; it was determined by the community and made open-source for maximum transparency.

Dog (Bitcoin)

$DOG.X is trending as the community rallies around its position as the first meme coin on Bitcoin, emphasizing its fair launch and strong community-driven growth. Discussion highlights its unique utility in strengthening the Bitcoin network through miner fees, setting it apart from other meme coins. Some believe $DOG.X has the potential to outperform other meme coins like $DOGE.X.

Summit Therapeutics, Inc. is a biopharmaceutical company, that focuses on the discovery, development, and commercialization of patient, physician, caregiver, and societal-friendly medicinal therapies intended to improve quality of life, increase potential duration of life, and resolve serious unmet medical needs. The firm conducts clinical programs focusing on Clostridioides Difficile Infection (CDI). Its lead product, Ridinilazole, is an orally administered small molecule antibiotic that is in Phase III clinical trials for the treatment of CDI. The company was founded in 2003 and is headquartered in Miami, FL.

Summit Therapeutics Inc

Summit Therapeutics is trending due to positive updated Phase 3 HARMONi data for its lung cancer drug, ivonescimab, sparking optimism about its potential. The community is focused on the drug's OS benefit and its competitive efficacy compared to existing treatments, while also debating the validity and interpretation of trial data. Some investors are speculating about a potential acquisition or partnership, particularly with AstraZeneca, driving further interest in the stock.

Dogecoin is a cryptocurrency based on the popular "Doge" Internet meme and features a Shiba Inu on its logo. Dogecoin is a Litecoin fork. Introduced as a "joke currency" on 6 December 2013, Dogecoin quickly developed its own online community and reached a capitalization of US$60 million in January 2014. Compared with other cryptocurrencies, Dogecoin had a fast initial coin production schedule: 100 billion coins were in circulation by mid-2015, with an additional 5.256 billion coins every year thereafter. As of 30 June 2015, the 100 billionth Dogecoin had been mined.   Dogecoin was created by Billy Markus from Portland, Oregon and  Jackson Palmer from Sydney, Australia. Both wanted to create a fun cryptocurrency that will appeal beyond the core Bitcoin audience. Dogecoin is primarily used as a tipping system on Reddit and Twitter where users tip each other for creating or sharing good content. The community is very active in organising fundraising activities for deserving causes.  The developers of Dogecoin haven’t made any major changes to the coin since 2015. This means that Dogecoin could get left behind and is why Shibas are leaving Dogecoin to join more advanced platforms like Ethereum. One of Dogecoin strengths is its relaxed and fun-loving community. However, this is also a weakness because other currencies are way more professional.  To purchase Dogecoin, it involves downloading a crypto wallet, setting up a crypto exchange account and then trading away for your desired crypto currency. Once we have set up an account with a DOGE currency exchange and deposited some funds, you are ready to start trading.

Dogecoin

Dogecoin is trending as the community discusses potential catalysts, including speculation around a Dogecoin ETF and its impact on price. Sentiment is focused on the potential for significant gains, with some looking toward the token reaching the $1 mark. The conversation also includes discussion around Dogecoin's relationship with other meme coins and their respective ecosystems.

DOVU

DOVU.X is trending as the community highlights its staking rewards and potential in the Real World Asset (RWA) space, particularly due to its "Trust Operating System." Recent news around partnerships and deals related to carbon credits and ecological projects may be acting as a catalyst. Community members are actively discussing its association with Hedera and potential for significant growth.

ProShares Trust - ProShares Short Dow30 -1x Shares

ProShares Short Dow30

$DOG is trending as the Bitcoin memecoin gains traction within the crypto community, with many touting its fair launch and strong community backing. Conversation highlights its potential to become the meme face of Bitcoin and draw comparisons to other popular memecoins. Community members are emphasizing its organic growth and decentralized nature.

The Children's Place, Inc. engages in the provision of apparel, footwear, accessories, and other items for children. The firm also designs contracts to manufacture and sell fashionable and value-priced merchandise under the brand names of The Children’s Place, Baby Place, and Gymboree. It operates through The Children’s Place U.S. and The Children’s Place International segments. The Children’s Place U.S. segment refers to the company’s U.S. and Puerto Rico-based stores and revenue from its U.S. based wholesale business. The Children’s Place International segment is involved in the Canadian-based stores, revenue from the company’s Canadian-based wholesale business, as well as revenue from international franchisees. The company was founded by David Pulver and Clinton A. Clark in 1969 and is headquartered in Secaucus, NJ.

Childrens Place Inc

Children's Place is trending due to recent earnings and guidance, with discussions centered on a potential short squeeze given its high short interest. Community members are debating the company's turnaround efforts and the impact of new management, with some highlighting positive comparable DTC sales and others expressing concerns about financials and potential bankruptcy. The stock's low float and high short interest are fueling speculation about a significant price movement.

Gyrodyne LLC engages in the management of a portfolio of medical office and industrial properties. Its properties include Flowerfield, Port Jefferson Professional Park, Courtland Medical Center, and Grove. The company was founded by Peter James Papadakos in 1946 and is headquartered in St. James, NY.

Gyrodyne LLC

GYRO is trending due to a recent land sale agreement, potentially boosting its NAV, which has captured the attention of traders. The stock's low float is fueling discussions of a potential squeeze, with community members actively watching for breakout levels. Some are betting on a significant upward move, drawing comparisons to other low-float runners.

Bankr is an advanced AI agent focused on simplifying the process of buying and selling digital assets. Bankr was the first AI agent on Farcaster to help you quickly buy all your favorites coins directly in the social. BankrCoin is the official coin of the agent and was deployed by Bankr itself directly in the Farcaster social feed. Fees from swaps go to support BankrCoin. Bankr is available on Farcaster and will soon be launching a private terminal, token recs, and limit orders on Base.

BankrCoin

BankrCoin is trending as traders discuss its recent listing on Coinbase and potential for high gains, with some community members pointing to its AI-powered trading platform and the possibility of new partnerships. Bullish sentiment is fueled by the hope of 'dropping zeros' and achieving significant market cap growth. Others are comparing it to similar tokens that have experienced substantial pumps.

Kratos Defense & Security Solutions, Inc. engages in the provision of mission critical products, services and solutions for United States national security priorities. It operates through the Kratos Government Solutions (KGS) and Unmanned Systems (US) segments. The KGS segment consists of an aggregation of KGS operating segments, including microwave electronic products, space, satellite and cyber, training solutions. The US segment refers to the unmanned aerial, unmanned ground, unmanned seaborne and related command, control and communications system businesses. The company was founded on December 19, 1994, and is headquartered in Round Rock, TX.

Kratos Defense & Security Solutions Inc

Kratos Defense is trending as community members discuss its potential involvement in upcoming military programs and the recent partnership with Airbus for European markets. Bullish sentiment is fueled by the company's positioning in the defense sector, particularly related to drone technology and hypersonic systems. Some investors are speculating about future contracts and a potential stock split, while others are noting technical indicators and potential resistance levels.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Shares of Theratechnologies Inc. (THTX) traded 46% higher on Friday noon after Michigan-based Future Pak LLC announced that it has submitted a fresh proposal to acquire all outstanding shares of the company’s common stock.Future Pak is a privately held contract manufacturer and packager of pharmaceutical and nutraceutical products.The company’s new proposal offers a cash consideration of $3.51 to $4.50 per share, implying a premium of 164% to 238% on Theratechnologies’ closing price of $1.33 on Thursday.The proposal represents an enterprise value of up to $255 million, including $205 million in cash and up to $50 million in contingent value right payments.Future Pak said the offer remains open for consideration by Theratechnologies and its Board. The contract manufacturer highlighted that it has submitted two formal proposals to Theratechnologies since January, including the recent proposal, but received minimal engagement from the company.Future Pak Chief Growth Officer Nirav Patel said the firm believes the proposal provides a “significant upside” and a “solid foundation” for constructive dialogue.The company added that the proposed transaction would not be subject to a financing contingency and has the full support of its strategic financial partner, Colbeck Capital Management.On Stocktwits, retail sentiment around Theratechnologies rose from ‘bearish’ to ‘extremely bullish’ territory over the past 24 hours while message volume jumped from ‘extremely low’ to ‘extremely high.’<figure class="image"><img style="aspect-ratio:1292/308;" src="https://news.stocktwits-cdn.com/Screenshot_2025_04_11_at_12_39_25_PM_png_ebb8e8c704.webp" alt="THTX's Sentiment Meter and Message Volume as of 12:40 p.m. ET on April 11, 2025 | Source: Stocktwits" width="1292" height="308"><figcaption>THTX's Sentiment Meter and Message Volume as of 12:40 p.m. ET on April 11, 2025 | Source: Stocktwits</figcaption></figure>A Stocktwits user opined that the proposal shows how undervalued the stock is.<stembedurl>https://stocktwits.com/s586576/message/611379645</stembedurl>Another, however, expressed surprise at why the Board did not accept the proposal despite its significant premium.<stembedurl>https://stocktwits.com/RSVinLA/message/611384955</stembedurl><a href="https://stocktwits.com/symbol/THTX">THTX stock</a> has gained nearly 6% in 2025 and about 31% over the past 12 months.Also See: <a href="https://stocktwits.com/news-articles/markets/equity/jpmorgans-jamie-dimon-sees-sp-500-earnings-estimates-contracting-due-to-trump-tariffs/chfroASRb9j">Jamie Dimon Sees S&amp;P 500 Earnings Estimates Contract As Trump Tariffs Force Companies To Withdraw Guidance</a>For updates and corrections, email newsroom[at]stocktwits[dot]com

Rising stock market chart on a trading board background.

Theratechnologies Stock Soars On Acquisition Bid From Future Pak: Retail’s Overjoyed

Future Pak’s proposal offers a cash consideration of $3.51 to $4.50 per share, implying a premium of 164% to 238% on Theratechnologies’ closing price of $1.33 on Thursday.

Equity

Shares of Theratechnologies Inc. (THTX) tumbled 16% on Wednesday after the company’s first-quarter <a target="_blank" rel="noopener noreferrer nofollow" href="https://www.theratech.com/news-releases/news-release-details/theratechnologies-reports-financial-results-first-quarter-2025">earnings</a> fell below Wall Street estimates.Theratechnologies reported a revenue of $19.05 million, marking a growth of 17.2% from the corresponding period last year, but below an analyst estimate of $20.43 million, according to FinChat data.Revenue from the sales of Egrifta SV, used to treat HIV-related excess visceral abdominal fat, jumped by nearly 45% due to higher unit sales and higher selling price.Unit sales rose as the company rebuilt its distributor and pharmacy inventories following a supply disruption resulting in a one-time loss of six to seven weeks of sales.CEO Paul Lévesque said that while the number is mainly related to reloading the pipeline following an end to the temporary supply disruption, the fundamentals of the business and specifically demand for Egrifta SV remains very strong.He added that the HIV portfolio led by the Egrifta franchise will continue to remain an “engine of growth” for years.The company reported positive adjusted earnings before interest, taxes, depreciation, and amortization (EBITDA) of $2.3 million, compared to a loss of $247,000 in the same quarter of 2024, but below an estimated $3.93 million.For the fiscal year 2025, the company estimates revenue in the range of $80 million to $83 million and adjusted EBITDA to be between $10 and $12 million, below an estimated $21.16 million.On Stocktwits, retail sentiment around Theratechnologies fell from ‘neutral’ to ‘bearish’ territory, coupled with ‘extremely low’ message volume over the past 24 hours.<figure class="image"><img style="aspect-ratio:651/148;" src="https://news.stocktwits-cdn.com/Screenshot_2025_04_09_at_12_04_56_PM_png_e8d5a9a3b7.webp" alt="THTX's Sentiment Meter and Message Volume as of 12:00 p.m. ET on April 9, 2025 | Source: Stocktwits" width="651" height="148"><figcaption>THTX's Sentiment Meter and Message Volume as of 12:00 p.m. ET on April 9, 2025 | Source: Stocktwits</figcaption></figure> <a href="https://stocktwits.com/symbol/THTX">THTX shares</a> have been down nearly 30% this year and over 16% over the past 12 months.Also See: <a href="https://stocktwits.com/news-articles/markets/equity/bernstein-downgrades-ford-motor-co-cuts-price-target/chfn9uoRbB2">Ford Stock In Spotlight After Bernstein Downgrade, Price Target Cut: Retail Stays Pessimistic</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

Stock market down on a black background. | Image source: Yuichiro Chino via Getty Images

Theratechnologies Stock Plummets On Disappointing Q1 Earnings, Full Year Forecast: Retail Sentiment Sours

For the fiscal year 2025, the company estimates revenue in the range of $80 million to $83 million and adjusted EBITDA to be between $10 and $12 million. 

Examining the Future: Theratechnologies's Earnings Outlook

Theratechnologies Faces Potential Supply Disruption For Its Top Selling Drug, Warns of Revenue Impact Due To Manufacturing Delays

Theratechnologies anticipates a temporary supply disruption of Egrifta SV in 2025 due to an FDA-linked manufacturer shutdown, but the company is working to minimize the impact while adjusting revenue...

HIV Medicine Maker Theratechnologies 'Wraps Up Strong Second Quarter,' Stock Soars

Theratechnologies reports Q2 2024 sales of $22.02 million, a 25.5% YoY increase, driven by strong demand for EGRIFTA SV. Net income reached $1 million with an adjusted EBITDA of $5.5 million. The...

Theratechnologies Appoints Elina Tea to its Board of Directors

MONTREAL, April 05, 2024 (GLOBE NEWSWIRE) -- Theratechnologies Inc. ( Theratechnologies or the Company ) (TSX: TH) (NASDAQ: THTX), a biopharmaceutical company focused on the development and...

Theratechnologies to Announce First Quarter 2024 Financial Results and Provide Business Update

MONTREAL, April 03, 2024 (GLOBE NEWSWIRE) -- Theratechnologies Inc. ( Theratechnologies or the Company ) (TSX: TH) (NASDAQ: THTX), a biopharmaceutical company focused on the development and...

Theratechnologies Inc. (NASDAQ:THTX) Short Interest Down 35.7% in March

Theratechnologies Inc. (NASDAQ:THTX - Get Free Report) was the recipient of a large drop in short interest in March. As of March 15th, there was short interest totalling 17,100 shares, a drop of...

Theratechnologies to Present Preclinical Data at AACR on Multiple PDCs Showcasing Potential of SORT1+Technology  Platform

Study to assess new camptothecin-peptide conjugates for the treatment of sortilin-positive colorectal cancers Separate data to highlight activity of sudocetaxel zendusortide (TH1902) to trigger the...

Theratechnologies Appoints Jordan Zwick to its Board of Directors

MONTREAL, March 21, 2024 (GLOBE NEWSWIRE) -- Theratechnologies Inc. ( Theratechnologies or the Company ) (TSX: TH) (NASDAQ: THTX), a biopharmaceutical company focused on the development and...

Theratechnologies, Inc. is a pharmaceutical company, which engages in addressing medical needs of patients with Human Immunodeficiency Virus (HIV). The firm offers its product under the brand name of EGRIFTA, which is an approved therapy for the reduction of excess abdominal fat in HIV-infected patients with lipodystrophy. The company was founded on October 19, 1993 and is headquartered in Montréal, Canada.

Fiscal Period	Estimated	Reported	Surprise	Result
Q3 '25	$0.01	--	--	N/A
Q2 '25	-$0.01	--	--	N/A
Q1 '25	$0.03	$0.00	-100.00%	MISSED
Q4 '24	$0.05	-$0.16	-420.00%	MISSED
Q3 '24	$0.03	$0.06	100.00%	BEAT

THTX
Theratechnologies Inc.

Feed

News

Sentiment

Earnings

Fundamentals

Info

Upcoming Earnings: Q3 '25

Historical Earnings

Latest THTX News

THTX Theratechnologies Inc.